Snelling T - Search Results

1

Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.

Leach AJ, Wilson N, Arrowsmith B, Beissbarth J, Mulholland EK, Santosham M, Torzillo PJ, McIntyre P, Smith-Vaughan H, Chatfield MD, Lehmann D, Binks M, Chang AB, Carapetis J, Krause V, Andrews R, Snelling T, Skull SA, Licciardi PV, Oguoma VM, Morris PS. Leach AJ, et al. Among authors: snelling t. Lancet Infect Dis. 2022 Sep;22(9):1374-1387. doi: 10.1016/S1473-3099(22)00272-9. Epub 2022 Jun 27. Lancet Infect Dis. 2022. PMID: 35772449 Clinical Trial.

2

Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting.

Snelling TL, Schultz R, Graham J, Roseby R, Barnes GL, Andrews RM, Carapetis JR. Snelling TL, et al. Clin Infect Dis. 2009 Aug 1;49(3):428-31. doi: 10.1086/600395. Clin Infect Dis. 2009. PMID: 19566443

3

Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia.

Snelling TL, Andrews RM, Kirkwood CD, Culvenor S, Carapetis JR. Snelling TL, et al. Clin Infect Dis. 2011 Jan 15;52(2):191-9. doi: 10.1093/cid/ciq101. Clin Infect Dis. 2011. PMID: 21288843

4

Duration of protection after first dose of acellular pertussis vaccine in infants.

Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Quinn HE, et al. Pediatrics. 2014 Mar;133(3):e513-9. doi: 10.1542/peds.2013-3181. Epub 2014 Feb 10. Pediatrics. 2014. PMID: 24515514

5

Nitazoxanide for the treatment of infectious diarrhoea in the Northern Territory, Australia 2007-2012.

McLeod C, Morris PS, Snelling TL, Carapetis JR, Bowen AC. McLeod C, et al. Among authors: snelling tl. Rural Remote Health. 2014;14(2):2759. Epub 2014 Jun 12. Rural Remote Health. 2014. PMID: 24924831 Free article.

6

Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology.

Sheridan SL, Frith K, Snelling TL, Grimwood K, McIntyre PB, Lambert SB. Sheridan SL, et al. Expert Rev Vaccines. 2014 Sep;13(9):1081-106. doi: 10.1586/14760584.2014.944167. Epub 2014 Aug 5. Expert Rev Vaccines. 2014. PMID: 25093268 Review.

7

Assessing the effect of meningitis prevention and treatment.

Snelling TL, McIntyre PB. Snelling TL, et al. Lancet Infect Dis. 2014 Sep;14(9):780-1. doi: 10.1016/S1473-3099(14)70873-4. Epub 2014 Aug 4. Lancet Infect Dis. 2014. PMID: 25104305 No abstract available.

8

Parental Tdap boosters and infant pertussis: a case-control study.

Quinn HE, Snelling TL, Habig A, Chiu C, Spokes PJ, McIntyre PB. Quinn HE, et al. Pediatrics. 2014 Oct;134(4):713-20. doi: 10.1542/peds.2014-1105. Epub 2014 Sep 15. Pediatrics. 2014. PMID: 25225136

9

Management of invasive group A streptococcal infections.

Waddington CS, Snelling TL, Carapetis JR. Waddington CS, et al. J Infect. 2014 Nov;69 Suppl 1:S63-9. doi: 10.1016/j.jinf.2014.08.005. Epub 2014 Oct 11. J Infect. 2014. PMID: 25307276 Review.

10

Transiently increased IgE responses in infants and pre-schoolers receiving only acellular Diphtheria-Pertussis-Tetanus (DTaP) vaccines compared to those initially receiving at least one dose of cellular vaccine (DTwP) - Immunological curiosity or canary in the mine?

Holt PG, Snelling T, White OJ, Sly PD, DeKlerk N, Carapetis J, Biggelaar AVD, Wood N, McIntyre P, Gold M. Holt PG, et al. Among authors: snelling t. Vaccine. 2016 Jul 29;34(35):4257-4262. doi: 10.1016/j.vaccine.2016.05.048. Epub 2016 Jun 11. Vaccine. 2016. PMID: 27265452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page